These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2657469)

  • 41. The phenylalanine and tyrosine contnet of maternal and fetal body fluids from rabbits fed aspartame.
    Ranney RE; Mares SE; Schroeder RE; Hutsell TC; Raczialowski FM
    Toxicol Appl Pharmacol; 1975 May; 32(2):339-46. PubMed ID: 1154399
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of aspartame ingestion on the carbohydrate-induced rise in tryptophan hydroxylation rate in rat brain.
    Fernstrom JD; Fernstrom MH; Grubb PE
    Am J Clin Nutr; 1986 Aug; 44(2):195-205. PubMed ID: 3728356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reanalysis of the effects of phenylalanine, alanine, and aspartame on food intake in human subjects.
    Rogers PJ; Blundell JE
    Physiol Behav; 1994 Aug; 56(2):247-50. PubMed ID: 7938234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of aspartame on N-methyl-D-aspartate-sensitive L-[3H]glutamate binding sites in rat brain synaptic membranes.
    Pan-Hou H; Suda Y; Ohe Y; Sumi M; Yoshioka M
    Brain Res; 1990 Jun; 520(1-2):351-3. PubMed ID: 1976410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V; Cochran C; Parker TF; Long DL; Ashby J; Gorman MA; Liepa GU
    Am J Clin Nutr; 1989 Jun; 49(6):1302-6. PubMed ID: 2729170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The neuropsychiatric effects of aspartame in normal volunteers.
    Lapierre KA; Greenblatt DJ; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1990 May; 30(5):454-60. PubMed ID: 2347957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct and indirect cellular effects of aspartame on the brain.
    Humphries P; Pretorius E; Naudé H
    Eur J Clin Nutr; 2008 Apr; 62(4):451-62. PubMed ID: 17684524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspartame--a sweet surprise.
    Mazur RH
    J Toxicol Environ Health; 1976 Sep; 2(1):243-9. PubMed ID: 994241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No change in spontaneous behavior of rats after acute oral doses of aspartame, phenylalanine, and tyrosine.
    Mullenix PJ; Tassinari MS; Schunior A; Kernan WJ
    Fundam Appl Toxicol; 1991 Apr; 16(3):495-505. PubMed ID: 1677339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspartame-sweetened beverage: effect on plasma amino acid concentrations in normal adults and adults heterozygous for phenylketonuria.
    Stegink LD; Wolf-Novak LC; Filer LJ; Bell EF; Ziegler EE; Krause WL; Brummel MC
    J Nutr; 1987 Nov; 117(11):1989-95. PubMed ID: 2890728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can aspartame meet our expectations?
    Horwitz DL; Bauer-Nehrling JK
    J Am Diet Assoc; 1983 Aug; 83(2):142-6. PubMed ID: 6348131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspartame--a review.
    Waggoner WF
    Pediatr Dent; 1984 Sep; 6(3):153-8. PubMed ID: 6596562
    [No Abstract]   [Full Text] [Related]  

  • 55. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.
    Boehm MF; Bada JL
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5263-6. PubMed ID: 6591191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurobiochemical alterations induced by the artificial sweetener aspartame (NutraSweet).
    Coulombe RA; Sharma RP
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):79-85. PubMed ID: 2420032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspartame and the rat brain monoaminergic system.
    Perego C; De Simoni MG; Fodritto F; Raimondi L; Diomede L; Salmona M; Algeri S; Garattini S
    Toxicol Lett; 1988 Dec; 44(3):331-9. PubMed ID: 2464204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspartame: review of safety.
    Butchko HH; Stargel WW; Comer CP; Mayhew DA; Benninger C; Blackburn GL; de Sonneville LM; Geha RS; Hertelendy Z; Koestner A; Leon AS; Liepa GU; McMartin KE; Mendenhall CL; Munro IC; Novotny EJ; Renwick AG; Schiffman SS; Schomer DL; Shaywitz BA; Spiers PA; Tephly TR; Thomas JA; Trefz FK
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 2):S1-93. PubMed ID: 12180494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals.
    Rowan AJ; Shaywitz BA; Tuchman L; French JA; Luciano D; Sullivan CM
    Epilepsia; 1995 Mar; 36(3):270-5. PubMed ID: 7614911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants.
    Filer LJ; Baker GL; Stegink LD
    J Nutr; 1983 Aug; 113(8):1591-9. PubMed ID: 6135765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.